Novo Nordisk takes a hit as CagriSema underperforms in weight loss
The Danish company has announced positive results from its Phase III trial of CagriSema but fell short of a previously promised 25% weight loss.
Sorriso Pharma’s UC treatment hits Phase Ib endpoints
APAC leading in Parkinson’s disease clinical trials
Vertex’s stock hurt after non-opioid pain drug shows benefit similar to placebo
Hansa Biopharma announces success in Guillain-Barré Syndrome trial
Prothena’s Parkinson’s study fails primary endpoint despite some success
Analysis
View More
Themes
View MoreFirst blood-stage malaria vaccine ‘a much-needed addition’ – analyst
Following positive Phase IIb trial results, RH5.1/Matrix-M could be the first blood-stage malaria vaccine brought to market.
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
CEPI funds safety project for vaccines in Africa
myTomorrows adds ISRCTN to clinical trial search
Generative AI has ‘potential to revolutionise clinical development’
‘Major milestone’ for UK clinical trials as new framework laid in parliament